TripleHelix Technologies Competitors

Sentinel Real Estate is an independently owned real estate investment management firm established in 1969, with a longstanding track record of managing institutional quality real estate assets for global investors. Headquartered in New York City, Sentinel maintains corporate offices in Europe, the UK and Australia and a broad operational footprint supporting investments across multiple markets and jurisdictions. The firm has experience developing, acquiring and managing diversified multifamily and commercial real estate properties. Sentinel operates a vertically integrated investment platform with in‑house capabilities spanning acquisitions, asset management, and property operations, including on‑site management. The firm’s senior leadership team is characterized by long tenure and deep institutional knowledge, supporting continuity, discipline, and consistency in execution.

About Genomic Health Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that help optimize cancer care by addressing the overtreatment of the disease, one of the greatest issues in healthcare today. With its Oncotype IQ® Genomic Intelligence Platform, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of clinical and genomic big data into actionable results for treatment planning throughout the cancer patient journey, from diagnosis to treatment selection and monitoring. The Oncotype IQ portfolio of genomic tests and services currently consists of the company's flagship line of Oncotype DX gene expression tests that have been used to guide treatment decisions for more than 750,000 cancer patients worldwide. Genomic Health is expanding its test portfolio to include additional liquid- and tissue-based tests, including the recently launched Oncotype SEQ® Liquid Select™ test. The company is based in Redwood City, California, with international headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn. About Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. The company's flagship product, the Oncotype DX Breast Recurrence Score®, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Additionally, the Oncotype DX Breast DCIS Score™ predicts the likelihood of recurrence in a pre-invasive form of breast cancer called DCIS. In prostate cancer, the Oncotype DX Genomic Prostate Score™ predicts disease aggressiveness and further clarifies the current and future risk of the cancer prior to treatment intervention. With more than 750,000 patients tested in more than 90 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. To learn more about Oncotype DX tests, visit www.OncotypeIQ.com, www.MyBreastCancerTreatment.org or www.MyProstateCancerTreatment.org.

Acme Furniture Industry Inc. ACME started doing business in Los Angeles, California in 1985. Today we have seven branches located in New York City, New Jersey, Atlanta, Miami, Dallas, Arizona, and San Franscico. From the beginning we have set out to provide our customers with service, value and quality. Service In our new 400,000 square foot fully racked warehouse in Los Angeles, we can ship out most orders within 48 hours. In most instances we can ship 90% of the items requested. This is possible due to the fact that we maintain a 12 million dollar inventory at all times. We also offer our customers a traffic department that offers the most competitive freight rates available. Value Over the years ACME has been working with many of the same factories in Malaysia, Taiwan, Vietnam, Indonesia, Brazil and of course China. Because of our long-term relationships with these factories, we have been able to purchase our products at the most competitive prices in the industry. We are proud to say that in most cases, ACME will be able to beat our competitor's prices. Quality Nothing is more important than quality. That is why ACME maintains its own quality control personnel in every country in which we do business. Every item must meet our exact standards. Nothing less will do. Integrity We are very proud of the growth ACME has realized since 1985. Besides the three branches we also maintain showrooms in Tupelo, Mississippi, High Point, North Carolina, San Francisco, California and our newest showroom in Las Vegas, Nevada. In addition, we value our loyal customers and the many friendships we have developed with our clientele. - See more at: http://www.acmecorp.com/aboutus.aspx#sthash.s9QMqJMn.dpuf